Trulieve Cannabis Corp. 8-K

What Happened
Trulieve Cannabis Corp. announced on June 3, 2026 (8-K filed June 4, 2026) that it completed a transaction to deconsolidate Harvest Enterprises, LLC (Harvest) from its consolidated financial results. The company’s indirect wholly‑owned subsidiary, Harvest Enterprises Holdings, Inc., now holds non‑voting, non‑participating units in Harvest that are convertible into common units only after the NYSE permits listing of companies that consolidate entities involved in non‑medical marijuana activities. The change is intended to segregate Trulieve’s mixed‑use cannabis business from its medical cannabis business to support a future application to list Trulieve’s subordinate voting shares on the NYSE.

Key Details

• Date: agreements executed June 3, 2026; 8‑K filed June 4, 2026. Trulieve will consolidate Harvest results through June 3, 2026 and deconsolidate thereafter; it will report the change and a non‑controlling interest in its Q2 10‑Q (to be filed by Aug 7, 2026).
• Investment: Whitley Holding 05192026, LLC (the Harvest Investor) purchased Class A (voting) units representing a 10% economic interest in Harvest for approximately $14.8 million.
• Governance: Harvest’s LLC agreement creates three unit classes (Voting Units, Common Units, Non‑Voting Units); Harvest Investor appoints two board members (Frank Whitley and Rudy Rowe) and Trulieve’s subsidiary appointed Kim Rivers. The LLC terms ensure Voting Units will remain at least 10% after any conversion, so Trulieve will not hold more than 90% of units at conversion.
• Agreements: Trulieve, its subsidiary and Harvest also entered a Protection Agreement (preserves value of Trulieve’s Non‑Voting Units but does not give control) and a Management Services Agreement under which a Trulieve subsidiary can provide services to Harvest for cost reimbursement plus a 5% margin (subject to a cap); either party may terminate the MSA with 90 days’ notice. Pro forma financial statements reflecting the deconsolidation were filed as Exhibit 99.1.

Why It Matters
For investors, this is a structural change that removes Harvest’s results from Trulieve’s consolidated financials as of June 3, 2026 and records Trulieve as holding a non‑controlling interest. The move is designed to separate mixed‑use (non‑medical) cannabis operations from medical operations to position Trulieve for a potential NYSE listing of its subordinate voting shares—subject to NYSE rule changes permitting companies that consolidate non‑medical marijuana activities. The transaction also reduces Trulieve’s direct control over Harvest (non‑voting units and outside board representation) while preserving an economic interest and a path to convert those units if and when listing rules change.